Flonase ads failed to disclose risk
The Food and Drug Administration claims that Glaxo Wellcome's Spanish-language television advertisements for Flonase® (fluticasone) nasal spray, which ran in Puerto Rico in 1998 and 1999, failed to disclose risk information.
The Food and Drug Administration claims that Glaxo Wellcome's Spanish-language television advertisements for Flonase® (fluticasone) nasal spray, which ran in Puerto Rico in 1998 and 1999, failed to disclose risk information.
In an August 18 warning letter to the company, the FDA said the ads failed "to provide information relating to the major side effects and contraindications" and failed to make "adequate provision for the dissemination of the approved labeling, or inclusion of the brief summary of information related to the side effects and contraindication in conjunction with the advertisement."
The FDA letter continued: "In fact, the advertisement mentions only the indication for Flonase (relief of nasal allergy symptoms) and provides no risk information at all."
In addition, Glaxo Wellcome failed to submit the ads to the FDA, which requires such submissions at the time of the advertisement's first use.
Glaxo Wellcome has discontinued the ads, but the FDA is requiring that the company "assure FDA that similar advertisements are not being disseminated anywhere in the United States or its territories and possessions." PR
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
